These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32191544)

  • 21. NCI Cooperative Clinical Trials Groups proceed with reorganization: new system aims to improve efficiency and address changing research needs.
    Printz C
    Cancer; 2013 Oct; 119(19):3423-4. PubMed ID: 24078257
    [No Abstract]   [Full Text] [Related]  

  • 22. Central clinical trials effort draws praise, criticism.
    Wang L
    J Natl Cancer Inst; 2003 Sep; 95(18):1354-5. PubMed ID: 13130104
    [No Abstract]   [Full Text] [Related]  

  • 23. Inclusion of Adolescents and Young Adults in Cancer Clinical Trials.
    Weiss AR; Hayes-Lattin B; Kutny MA; Stock W; Stegenga K; Freyer DR
    Semin Oncol Nurs; 2015 Aug; 31(3):197-205. PubMed ID: 26210198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.
    Barrett NJ; Rodriguez EM; Iachan R; Hyslop T; Ingraham KL; Le GM; Martin K; Haring RC; Rivadeneira NA; Erwin DO; Fish LJ; Middleton D; Hiatt RA; Patierno SR; Sarkar U; Gage-Bouchard EA
    Cancer; 2020 Mar; 126(5):1077-1089. PubMed ID: 31909824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful recruitment and retention of diverse participants in a genomics clinical trial: a good invitation to a great party.
    Horowitz CR; Sabin T; Ramos M; Richardson LD; Hauser D; Robinson M; Fei K
    Genet Med; 2019 Oct; 21(10):2364-2370. PubMed ID: 30948857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early warning: an ailing canary in the mine.
    Dilts DM
    J Clin Oncol; 2010 Aug; 28(24):3799-800. PubMed ID: 20644096
    [No Abstract]   [Full Text] [Related]  

  • 27. An AI boost for clinical trials.
    Woo M
    Nature; 2019 Sep; 573(7775):S100-S102. PubMed ID: 31554996
    [No Abstract]   [Full Text] [Related]  

  • 28. Who's Eligible Anyway? Risk Modeling for Clinical Trial Accrual.
    Mileham KF; Kim ES
    Clin Cancer Res; 2016 Nov; 22(22):5397-5399. PubMed ID: 27601589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Researchers left to guess at outcomes of most cancer clinical trials.
    Twombly R
    J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774
    [No Abstract]   [Full Text] [Related]  

  • 30. Improving the conduct of cancer trials in the USA.
    Lancet; 2010 Apr; 375(9724):1408. PubMed ID: 20417838
    [No Abstract]   [Full Text] [Related]  

  • 31. The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway.
    Gordon I; Paoloni M; Mazcko C; Khanna C
    PLoS Med; 2009 Oct; 6(10):e1000161. PubMed ID: 19823573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer costs.
    Nature; 2013 Mar; 495(7440):142. PubMed ID: 23495394
    [No Abstract]   [Full Text] [Related]  

  • 33. Through the Lens of Patient Partners: Challenges in Accrual of Older Adults to NCI Clinical Trials.
    BrintzenhofeSzoc K; Canin B; Casas-Silva E; Denicoff A; Braun-Inglis C; Okado I; Bakos A
    J Natl Cancer Inst Monogr; 2022 Dec; 2022(60):125-134. PubMed ID: 36519817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resource.
    Wujcik D; Wolff SN
    J Health Care Poor Underserved; 2010 Feb; 21(1 Suppl):38-50. PubMed ID: 20173284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using a multistakeholder collaboratory and patient surveys to inform the conduct of personalized (N-of-1) trials.
    Derby L; Kronish IM; Wood D; Cheung YKK; Cohn E; Duan N; St Onge T; Duer-Hefele J; Davidson KW; Moise N
    Health Psychol; 2021 Apr; 40(4):230-241. PubMed ID: 33856830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials.
    Unger JM; Blanke CD; LeBlanc M; Hershman DL
    JAMA Netw Open; 2020 Jun; 3(6):e2010651. PubMed ID: 32478845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life and symptom management research sponsored by the National Cancer Institute.
    Minasian LM; O'Mara AM; Reeve BB; Denicoff AM; Kelaghan J; Rowland JH; Trimble EL;
    J Clin Oncol; 2007 Nov; 25(32):5128-32. PubMed ID: 17991932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing disparities in the burden of cancer: the role of patient navigators.
    Fowler T; Steakley C; Garcia AR; Kwok J; Bennett LM
    PLoS Med; 2006 Jul; 3(7):e193. PubMed ID: 16805649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overhaul of NCI Clinical Trial System Still in Progress.
    Nicholas J
    J Natl Cancer Inst; 2013 Aug; 105(15):1067-8. PubMed ID: 23884052
    [No Abstract]   [Full Text] [Related]  

  • 40. A call to action: patients' access to clinical trials.
    Sadler GS
    Health Soc Work; 2001 Aug; 26(3):196-200. PubMed ID: 11531196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.